E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/6/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

NeoStem settles $1.75 million private placement

By Sheri Kasprzak

New York, Sept. 6 - NeoStem, Inc. concluded a private placement for $1.75 million.

The terms of the offering could not be determined by press time Wednesday.

The offering is the second financing the company has completed within the past three months. On June 12, the company settled a $2,079,000 financing with DC Associates, LLC.

NeoStem had previously operated under the name Phase III Medical, Inc.

The funds raised from the two financings will be used to develop the company's intellectual property.

New York-based NeoStem develops technologies that allow adults to have their stem cells collected and banked for future use.

On Wednesday, the company's stock slipped by 7.14%, or 5 cents, to end at $0.65 (OTCBB: NEOI).


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.